Annual Working Capital
$122.87 M
+$107.56 M+702.15%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual working capital is $122.87 million, with the most recent change of +$107.56 million (+702.15%) on December 31, 2023.
- During the last 3 years, IMNM annual working capital has risen by +$83.02 million (+208.29%).
- IMNM annual working capital is now at all-time high.
Performance
IMNM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$204.51 M
-$39.87 M-16.32%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly working capital is $204.51 million, with the most recent change of -$39.87 million (-16.32%) on September 30, 2024.
- Over the past year, IMNM quarterly working capital has increased by +$81.64 million (+66.44%).
- IMNM quarterly working capital is now -27.62% below its all-time high of $282.56 million, reached on March 31, 2024.
Performance
IMNM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IMNM Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +702.1% | +66.4% |
| 3 y3 years | +208.3% | +1235.1% |
| 5 y5 years | +10000.0% | +1235.1% |
IMNM Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +702.1% | -27.6% | +1457.1% |
| 5 y | 5-year | at high | +8333.4% | -27.6% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -27.6% | >+9999.0% |
Immunome Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $204.51 M(-16.3%) |
| Jun 2024 | - | $244.38 M(-13.5%) |
| Mar 2024 | - | $282.56 M(+130.0%) |
| Dec 2023 | $122.87 M(+702.2%) | $122.87 M(+79.9%) |
| Sep 2023 | - | $68.30 M(+420.0%) |
| Jun 2023 | - | $13.13 M(-39.5%) |
| Mar 2023 | - | $21.70 M(+41.7%) |
| Dec 2022 | $15.32 M | $15.32 M(-30.0%) |
| Sep 2022 | - | $21.87 M(-24.5%) |
| Jun 2022 | - | $28.98 M(-20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $36.60 M(-22.0%) |
| Dec 2021 | $46.91 M(+17.7%) | $46.91 M(-12.2%) |
| Sep 2021 | - | $53.42 M(-9.9%) |
| Jun 2021 | - | $59.29 M(+62.3%) |
| Mar 2021 | - | $36.54 M(-8.3%) |
| Dec 2020 | $39.86 M(+2635.5%) | $39.86 M(+1818.9%) |
| Sep 2020 | - | $2.08 M(-71.9%) |
| Jun 2020 | - | $7.40 M(+408.0%) |
| Dec 2019 | $1.46 M(+164.9%) | $1.46 M |
| Dec 2018 | $550.00 K | - |
FAQ
- What is Immunome annual working capital?
- What is the all time high annual working capital for Immunome?
- What is Immunome annual working capital year-on-year change?
- What is Immunome quarterly working capital?
- What is the all time high quarterly working capital for Immunome?
- What is Immunome quarterly working capital year-on-year change?
What is Immunome annual working capital?
The current annual working capital of IMNM is $122.87 M
What is the all time high annual working capital for Immunome?
Immunome all-time high annual working capital is $122.87 M
What is Immunome annual working capital year-on-year change?
Over the past year, IMNM annual working capital has changed by +$107.56 M (+702.15%)
What is Immunome quarterly working capital?
The current quarterly working capital of IMNM is $204.51 M
What is the all time high quarterly working capital for Immunome?
Immunome all-time high quarterly working capital is $282.56 M
What is Immunome quarterly working capital year-on-year change?
Over the past year, IMNM quarterly working capital has changed by +$81.64 M (+66.44%)